Exhale

The official blog of the Lung Institute.

Emphysema Prognosis and Treatment Options

27 Feb 2017
| Under Disease Education, Emphysema, Medical, Treatments | Posted by
| 24 Comments
Emphysema Prognosis and Treatment Options

People living with emphysema often cope with difficult emphysema symptoms. These symptoms include shortness of breath, fatigue and coughing among others. Emphysema and chronic bronchitis fall under the larger disease category of chronic obstructive pulmonary disease (COPD). Emphysema, chronic bronchitis and COPD affect people differently. For some people emphysema progresses quickly, and for others, it progresses slowly. Because emphysema affects people differently, it is often hard for people to know their exact emphysema prognosis. Here is the information you need to know about emphysema prognosis and treatment options.

What is Emphysema?

Emphysema damages the lungs’ tiny air sacs (alveoli). The alveoli bring oxygen to the bloodstream. However, in emphysema, holes form in the inner walls of the alveoli. As emphysema progresses, the airways leading to the alveoli lose their elasticity. Eventually, the weakened air sacs collapse and trap oxygen in the lungs.

COPD, which includes emphysema and chronic bronchitis, makes it difficult for people to exhale old air fully. When people with emphysema take a breath, the old air cannot get out completely, so new air cannot get inside. People with emphysema struggle to breathe and often have trouble receiving enough oxygen.

Your emphysema prognosis depends on how advanced your emphysema is and the severity of your emphysema symptoms.

Emphysema Causes

In fact, emphysema can result from a variety of causes. The most common causes include:

  • Genetics
  • Cigarette Smoking
  • Alpha-1 Antitrypsin Deficiency
  • Long-term Exposure to Environmental Air Pollutants

Emphysema Prognosis

Emphysema Prognosis and Treatment Options

Currently, there is no cure for emphysema, chronic bronchitis, COPD or other chronic lung diseases. To diagnose and better understand the severity of your emphysema, your doctor may take a detailed medical history, run tests and recommend certain procedures.

For example, many doctors perform pulmonary function tests (PFTs) to help them diagnose the condition, understand the severity and what treatments could work best. PFTs measure how well your lungs and current treatment plan are working.

Your doctor may also perform a 6-minute walk test to assess your exercise tolerance. In addition, chest x-rays, blood tests and CT scans may be needed. After performing tests, your doctor may place your emphysema into stages. The emphysema stages help you and your doctor better understand the severity of your symptoms and your emphysema prognosis.

Emphysema Stages

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created the GOLD System to place certain chronic lung diseases into stages. The GOLD System uses the forced expiratory volume in one second (FEV1) measurement from a PFT to categorize emphysema and COPD. In the GOLD System, the emphysema stages are as follows:

  • Very mild or Stage 1: Very mild emphysema with a FEV1 about 80 percent or more of normal.
  • Moderate or Stage 2: Moderate emphysema with a FEV1 between 50 and 80 percent of normal.
  • Severe or Stage 3: Severe emphysema with FEV1 between 30 and 50 percent of normal.
  • Very severe or Stage 4: Very severe emphysema with a lower FEV1 than Stage 3, or those with Stage 3 FEV1 and low blood oxygen levels.

While these stages are helpful, nobody can accurately predict emphysema prognosis or emphysema life expectancy. However, doctors can use tests and procedures to estimate emphysema prognosis and life expectancy.

Hearing that there isn’t a cure may sound like a bleak emphysema prognosis, but there are treatment options available to manage emphysema symptoms.

Emphysema Treatment Options

Emphysema Prognosis and Treatment Options

Emphysema treatment options work to manage symptoms, so people can breathe better. Traditional treatments include bronchodilator inhalers, corticosteroids, combination inhalers, antibiotics and oxygen therapy.

Bronchodilators help open the airways and relax the muscles around the airways. Corticosteroids help reduce inflammation. Combination inhalers typically combine a bronchodilator and an inhaled corticosteroid into the same inhaler.

For an infection, antibiotics may be prescribed. Often, people with emphysema have trouble getting enough oxygen and experience low blood oxygen levels. Sometimes, oxygen therapy is used to help people maintain a better blood oxygen level.

Emphysema causes many people to feel short of breath, especially during activity. It’s normal to avoid doing activities that make you feel breathless. However, it’s been shown that even gentle exercises like walking strengthen muscles and improve stamina. Ask your doctor about what amount and type of exercise is best for you.

Diet can affect emphysema as well. Avoid foods that cause excess gas and bloating, such as fried foods, broccoli, cabbage and carbonated beverages. Try baked foods, steamed vegetables, fruit smoothies and water instead. Check out these COPD-friendly foods for more ideas, and remember to talk with your doctor before changing your diet.

For some people, trying an alternative treatment, such as cellular therapy, has helped them return to their favorite activities. Cellular therapy works to promote healing from within the lungs and may improve quality of life. In fact, many of our patients have reported feeling better and breathing with more ease after treatment. Under the supervision of their doctor, some patients have reduced or come off of their oxygen therapy. If you or a loved one has emphysema, COPD, chronic bronchitis or another chronic lung disease and would like to learn more about cellular therapy options, contact us at (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.